Insider Transactions in Q2 2023 at Anavex Life Sciences Corp. (AVXL)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 29
2023
|
Christopher U Missling President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
232,000
+15.65%
|
$232,000
$1.6 P/Share
|
|
Jun 28
2023
|
Christopher U Missling President and CEO |
SELL
Open market or private sale
|
Direct |
268,000
-20.84%
|
$1,876,000
$7.98 P/Share
|
|
Jun 28
2023
|
Christopher U Missling President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
268,000
+17.24%
|
$268,000
$1.6 P/Share
|